Scientists have discovered that losing a key protein in small cell lung cancer triggers inflammation that actually helps ...

Committee for Medicinal Products for Human Use (CHMP) adopted positive opinions for two drugs for the treatment of adults ...

The findings could fill a treatment gap for patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC) who also carry TP53 mutations.

Chemotherapy-induced myelosuppression (CIM) remains one of the most significant and underappreciated barriers to delivering ...

KRAS G12D-targeted protein degrader setidegrasib showed antitumor activity with tolerable safety profile in patients with ...

Tagrisso combined with chemotherapy improved how long patients with EGFR- and TP53-mutant NSCLC lived without their cancer ...

CLEVELAND, Ohio — A drug developed decades ago by an Ohio University professor shows new potential to make ...

Pharmacosmos initiates phase III clinical trial of trilaciclib in limited-stage small cell lung cancer MORRISTOWN, NJ, ...

As more states legalize marijuana, many people might be wondering if that means it is safe to use. While smoking tobacco is a ...

Nuvation Bio and Eisai's marketing authorization application for a non-small cell lung cancer treatment was accepted for review in Europe. The companies said Thursday the European Medicines Agency ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai"), a human-centered global leading research-based ...